Tom Bretschneider

ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 6

Top Venues

SLAS discovery : advancing life sciences R & D

SLAS technology

Disease models & mechanisms

Boehringer Ingelheim Pharma GmbH and Co KG Biberach

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Boehringer Ingelheim Pharma GmbH and Co KG Biberach Feb 01 2016

Germany

Principial Scientist :: Bioanalysis

Boehringer Ingelheim Pharma GmbH and Co KG Biberach Nov 01 2013 - Jan 31 2016

Germany

PostDoc

Publications

Jelena Weckerle, Sergio Picart-Armada, Stephan Klee, Tom Bretschneider, Andreas H Luippold, Wolfgang Rist, Christian Haslinger, Holger Schlüter, Matthew J Thomas, Bartlomiej Krawczyk, Francesc Fernandez-Albert, Marc Kästle, Daniel Veyel
Mapping the metabolomic and lipidomic changes in the Bleomycin model of pulmonary fibrosis in young and aged mice. Disease models & mechanisms (2021)
Roman P Simon, Martin Winter, Carola Kleiner, Lucie Wehrle, Michael Karnath, Robert Ries, Markus Zeeb, Gisela Schnapp, Dennis Fiegen, Tim T Häbe, Frank Runge, Tom Bretschneider, Andreas H Luippold, Daniel Bischoff, Wolfgang Reindl, Frank H Büttner
MALDI-TOF-Based Affinity Selection Mass Spectrometry for Automated Screening of Protein-Ligand Interactions at High Throughput. SLAS discovery : advancing life sciences R & D 26 (1) (2020)
Roman P Simon, Martin Winter, Carola Kleiner, Robert Ries, Gisela Schnapp, Annekatrin Heimann, Jun Li, Ljiljana Zuvela-Jelaska, Tom Bretschneider, Andreas H Luippold, Wolfgang Reindl, Daniel Bischoff, Frank H Büttner
MALDI-TOF Mass Spectrometry-Based High-Throughput Screening for Inhibitors of the Cytosolic DNA Sensor cGAS. SLAS discovery : advancing life sciences R & D 25 (4) (2019)
Tom Bretschneider, Can Ozbal, Markus Holstein, Martin Winter, Frank H Buettner, Sven Thamm, Daniel Bischoff, Andreas H Luippold
RapidFire BLAZE-Mode Is Boosting ESI-MS Toward High-Throughput-Screening. SLAS technology 24 (4) (2019)
Martin Winter, Tom Bretschneider, Sven Thamm, Carola Kleiner, Daniel Grabowski, Sarah Chandler, Robert Ries, Jörg Thomas Kley, Danielle Fowler, Christina Bartlett, Ralph Binetti, John Broadwater, Andreas H Luippold, Daniel Bischoff, Frank H Büttner
Chemical Derivatization Enables MALDI-TOF-Based High-Throughput Screening for Microbial Trimethylamine (TMA)-Lyase Inhibitors. SLAS discovery : advancing life sciences R & D 24 (7) (2019)
Martin Winter, Tom Bretschneider, Carola Kleiner, Robert Ries, Jörg P Hehn, Norbert Redemann, Andreas H Luippold, Daniel Bischoff, Frank H Büttner
Establishing MALDI-TOF as Versatile Drug Discovery Readout to Dissect the PTP1B Enzymatic Reaction. SLAS discovery : advancing life sciences R & D 23 (6) (2018)

Tom Bretschneider.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tom Bretschneider